NCT04103346

Brief Summary

Exposure to fine particulate matter (PM2.5) air pollution is an established risk factor for cardiovascular (CV) morbidity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 25, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

February 24, 2020

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 16, 2026

Completed
Last Updated

January 16, 2026

Status Verified

December 1, 2025

Enrollment Period

4.7 years

First QC Date

September 18, 2019

Results QC Date

October 31, 2025

Last Update Submit

December 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Systolic Blood Pressure

    Systolic blood pressure was measured twice a day, in the morning and the evening, from Tuesday through Friday during the first and fourth week of each of the four-week periods in which participants were exposed to one of the interventions. Results reflect the average of systolic readings taken.

    10 weeks

Secondary Outcomes (8)

  • Diastolic Blood Pressure

    10 weeks

  • Atmospheric Particulate Matter (pm2.5) - Indoor

    10 weeks

  • Atmospheric Particulate Matter (pm2.5) - Outdoor

    10 weeks

  • 24-hr Personal PM2.5 (Filter-gravimetric Mass)

    2 days

  • Black Carbon, Hourly Personal PM2.5 Levels

    10 weeks

  • +3 more secondary outcomes

Study Arms (2)

air filtration with hepa filter

ACTIVE COMPARATOR

air purifier used is the Holmes HAP8650B-NU-1 with the hepa filter inserted.

Other: air filtration with air purifier with hepa filter

air filtration with hepa filter removed

SHAM COMPARATOR

sham comparator uses the Holmes HAP8650B-NU-1 air purifier to be operated with the filter removed.

Other: sham

Interventions

shamOTHER

air purifier running with air filter removed

Also known as: air purifier running with air filter removed
air filtration with hepa filter removed

long-term (4 week) air filtration with the Holmes HAP8650B-NU-1 air purifier in the residence of low-income seniors impacted by roadway pollutants.

Also known as: air filtration
air filtration with hepa filter

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Nonsmoker
  • ≥60 years old
  • residing in Carpenter Place Apartments

You may not qualify if:

  • Active cigarette smoker
  • daily secondhand smoke exposure (self-report)
  • any CV event (myocardial infarction, stroke, heart failure, revascularization) in the past 3 months
  • unstable CV condition or risk factor (uncontrolled diabetes, class 3-4 angina or heart failure) or any medical condition that would place the participant at risk from participation or jeopardize study integrity (per investigators)
  • expected overnight travel outside their apartment during the 14-week study period
  • unable to provide informed consent
  • lung disease requiring oxygen
  • renal dialysis
  • cancer receiving active treatment or chemotherapy
  • severe uncontrolled high BP ≥160/100 mm Hg or SBP\<115 mm Hg.
  • CV medication change in the prior month. If participants are on medications for high BP, diabetes, or a CV condition, they will need to have stable therapy during the prior month with no planned changes during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48103, United States

Location

MeSH Terms

Interventions

Air Filterssalicylhydroxamic acid

Intervention Hierarchy (Ancestors)

FiltrationChemistry Techniques, AnalyticalInvestigative TechniquesEquipment and Supplies

Results Point of Contact

Title
Geoff Barnes
Organization
University of Michigan

Study Officials

  • Robert Brook, MD

    Wayne State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
filtration units with or without filters. filters are placed by research assistant from the environmental college and researchers performing the health outcomes are blinded to the condition (sham or active filtration) along with the subject.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: crossover of active filtration in subject's residence with a home filtration unit (Holmes air filtration unit Model HAP8650B-NU-1) versus an inactive sham filtration
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Internal Medicine

Study Record Dates

First Submitted

September 18, 2019

First Posted

September 25, 2019

Study Start

February 24, 2020

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

January 16, 2026

Results First Posted

January 16, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations